Cargando…
Hypoxia Regulates DPP4 Expression, Proteolytic Inactivation, and Shedding from Ovarian Cancer Cells
The treatment of ovarian cancer has not significantly changed in decades and it remains one of the most lethal malignancies in women. The serine protease dipeptidyl peptidase 4 (DPP4) plays key roles in metabolism and immunity, and its expression has been associated with either pro- or anti-tumour e...
Autores principales: | Moffitt, Laura R., Bilandzic, Maree, Wilson, Amy L., Chen, Yiqian, Gorrell, Mark D., Oehler, Martin K., Plebanski, Magdalena, Stephens, Andrew N. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7672561/ https://www.ncbi.nlm.nih.gov/pubmed/33143089 http://dx.doi.org/10.3390/ijms21218110 |
Ejemplares similares
-
DPP4 Inhibitor Sitagliptin Enhances Lymphocyte Recruitment and Prolongs Survival in a Syngeneic Ovarian Cancer Mouse Model
por: Wilson, Amy L., et al.
Publicado: (2021) -
Non-Invasive Fluorescent Monitoring of Ovarian Cancer in an Immunocompetent Mouse Model
por: Wilson, Amy L., et al.
Publicado: (2018) -
Therapeutic Targeting of Collective Invasion in Ovarian Cancer
por: Moffitt, Laura, et al.
Publicado: (2019) -
Chemoresistance is mediated by ovarian cancer leader cells in vitro
por: Karimnia, Nazanin, et al.
Publicado: (2021) -
A Novel Predictive Multi-Marker Test for the Pre-Surgical Identification of Ovarian Cancer
por: Stephens, Andrew N., et al.
Publicado: (2023)